The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
Open accessAbstract
OBJECTIVES: Ecstasy (3,4-methylenedioxymethamphetamine (MDMA) and related congerers: MDA, MDEA) is the name given to a group of popular recreational drugs. Animal data raise concern about neurotoxic effects of high doses of ecstasy on central serotonergic systems. The threshold dose for neurotoxicity in humans is not clear and serotonin is involved in several functions including cognition. The purpose of this study was to investigate cognitive performance in a group of typical recreational ecstasy users. METHODS: A comprehensive cognitive test battery was administered to 28 abstinent ecstasy users with concomitant use of cannabis only and to two equally sized matched groups of cannabis users and non-users. The sample consisted of ecstasy users with a typical recreational use pattern and did not include very heavy users. RESULTS: Ecstasy users were unimpaired in simple tests of attention (alertness). However, they performed worse than one or both control groups in the more complex tests of attention, in memory and learning tasks, and in tasks reflecting aspects of general intelligence. Heavier ecstasy and heavier cannabis use were associated with poorer performance in the group of ecstasy users. By contrast, the cannabis users did not differ significantly in their performance from the non-users. CONCLUSIONS: The present data raise concern that use of ecstasy possibly in conjunction with cannabis may lead to cognitive decline in otherwise healthy young people. Although the nature of the emerging cognitive disturbance is not yet clear, an impairment of working memory might be the common denominator underlying or contributing to declines of performance in various tasks. The cognitive disturbance is likely to be related to the well recognised neurotoxic potential of ecstasy. The data suggest that even typical recreational doses of ecstasy are sufficient to cause neurotoxicity in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baddeley, A. (1992) · Science · doi:10.1126/science.1736359 · Cited by 5,258
Linnoila, M., Virkkunen, M., Scheinin, M., Nuutila, A., Rimon, R., & Goodwin, F. K. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90344-2 · Cited by 1,308
Human memory and the medial temporal region of the brain.
Corsi, P. M. (1972) · McGill University · doi:10.82308/6355 · Cited by 1,294
Coccaro, E. F. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810070013002 · Cited by 1,086
Reconciling the role of central serotonin neurons in human and animal behavior
Soubrié, P. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00022871 · Cited by 996
McCann, U., Szabo, Z., Scheffel, U., Dannals, R., & Ricaurte, G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04329-3 · Cited by 660
O'Hearn, E., Battaglia, G., De Souza, E., Kuhar, M., & Molliver, M. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02788.1988 · Cited by 542
Battaglia, G., Yeh, S. Y., O'Hearn, E., Molliver, M. E., Kuhar, M. J., & De Souza, E. B. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39191-3 · Cited by 458
Memory impairment in abstinent MDMA ("Ecstasy") users
Bolla, K. I., McCann, U. D., & Ricaurte, G. A. (1998) · Neurology · doi:10.1212/wnl.51.6.1532 · Cited by 373
Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals
Ricaurte, G., Bryan, G., Strauss, L., Seiden, L., & Schuster, C. (1985) · Science · doi:10.1126/science.4023719 · Cited by 367
Attention, intelligence, and the frontal lobes.
Duncan, J. (1995) · Cited by 363
Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance
Parrott, A. C., & Lasky, J. (1998) · Psychopharmacology · doi:10.1007/s002130050714 · Cited by 340
Hatzidimitriou, G., McCann, U. D., & Ricaurte, G. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05096.1999 · Cited by 339
McCann, U. D., Ridenour, A., Shaham, Y., & Ricaurte, G. A. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.15 · Cited by 332
MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons
Battaglia, G., Yeh, S. Y., & De Souza, E. B. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90155-4 · Cited by 312
Ricaurte, G. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410010059035 · Cited by 300
McCann, U. D., Mertl, M., Eligulashvili, V., & Ricaurte, G. A. (1999) · Psychopharmacology · doi:10.1007/s002130050967 · Cited by 300
Arousal systems and attention.
Robbins, T. W., & Everitt, B. J. (1995) · Cited by 289
Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated Impulsivity
Morgan, M. J. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00012-8 · Cited by 288
Serotonin, memory, and the aging brain
McEntee, W. J., & Crook, T. H. (1991) · Psychopharmacology · doi:10.1007/bf02244194 · Cited by 284
CURRAN, H. V., & TRAVILL, R. A. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02951.x · Cited by 282
Memory deficits associated with recreational use of "ecstasy" (MDMA)
Morgan, M. J. (1999) · Psychopharmacology · doi:10.1007/s002130050803 · Cited by 281
Fischer, C., Hatzidimitriou, G., Wlos, J., Katz, J., & Ricaurte, G. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05476.1995 · Cited by 268
Ricaurte, G. A., Martello, A. L., Katz, J. L., & Martello, M. B. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11083-5 · Cited by 268
Neurotoxicity of MDMA and Related Compounds: Anatomic Studiesa
MOLLIVER, M. E., BERGER, U. V., MAMOUNAS, L. A., MOLLIVER, D. C., O'HEARN, E., & WILSON, M. A. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16916.x · Cited by 252
Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits
Parrott, A. C., Lees, A., Garnham, N. J., Jones, M., & Wesnes, K. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200110 · Cited by 223
Brain serotonin, type II alcoholism and impulsive violence.
Virkkunen, M., & Linnoila, M. (1993) · Journal of Studies on Alcohol, Supplement · doi:10.15288/jsas.1993.s11.163 · Cited by 211
Altman, H. J., & Normile, H. J. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80124-6 · Cited by 181
O'Keane, V., Moloney, E., O'Neill, H., O'Connor, A., Smith, C., & Dinan, T. G. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.5.643 · Cited by 172
Krystal, J. H., Price, L. H., Opsahl, C., Ricaurte, G. A., & Heninger, G. R. (1992) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999209026070 · Cited by 168
Wilson, M. A., Ricaurte, G. A., & Molliver, M. E. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90237-6 · Cited by 156
Serotonergic function after (±)3,4-methylene-dioxymethamphetarnine (‘Ecstasy’) in humans
Gerra, G., Zaimovic, A., Giucastro, G., Maestri, D., Monica, C., Sartori, R., Caccavari, R., & Delsignore, R. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199801000-00001 · Cited by 145
Helmstaedter, C., & Durwen, H. F. (1990) · PubMed · Cited by 140
Light, L. L. (1996) · Elsevier eBooks · doi:10.1016/b978-012102570-0/50015-x · Cited by 134
Experimental studies on the role of serotonin in cognition
Sirviö, J., Riekkinen, P. J., Jäkälä, P., & Riekkinen, P. J. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90060-4 · Cited by 113
Schmidt, C. J. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90782-5 · Cited by 91
Dexfenfluramine and 8-OH-DPAT modulate impulsivity in a delay-of-reward paradigm
Poulos, C. X., Parker, J. L., & Lê, A. D. (1996) · Behavioural Pharmacology · doi:10.1097/00008877-199608000-00011 · Cited by 77
Serotonin and human information processing: fluvoxamine can improve reaction time performance
Hasbroucq, T., Rihet, P., Blin, O., & Possamaï, C.-A. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00451-5 · Cited by 59
2.2 Neuropsychologische Diagnostik
(2012) · Thieme eBooks · doi:10.1055/b-0034-22427 · Cited by 12
Cited by
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Mild Chronic Hyponatremia Is Associated With Falls, Unsteadiness, and Attention Deficits
Renneboog, B., Musch, W., Vandemergel, X., Manto, M. U., & Decaux, G. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.09.026 · Cited by 895
Dose-related neurocognitive effects of marijuana use
Bolla, K. I., Brown, K., Eldreth, D., Tate, K., & Cadet, J. L. (2002) · Neurology · doi:10.1212/01.wnl.0000031422.66442.49 · Cited by 608
A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions
KELLY, E., DARKE, S., & ROSS, J. (2004) · Drug and Alcohol Review · doi:10.1080/09595230412331289482 · Cited by 438
Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study
GRANT, I., GONZALEZ, R., CAREY, C. L., NATARAJAN, L., & WOLFSON, T. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703950016 · Cited by 411
Metadata
- Authors
- Gouzoulis-Mayfrank, E.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2000-06-01
- Volume
- 68
- Issue
- 6
- Pages
- 719-725
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2166756269
- Cited by
- 305
- References
- 39
- FWCI
- 34.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.